Thanks to an ever increasing array of sophisticated techniques, neuroimaging has become an integral part of clinical neurology and a major tool in the neurosciences. Because, undoubtedly, the role of neuroimaging will grow even further, a Task-force on Neuroimaging was created by the EFNS in June 1996 to assess how academic neurology in Europe should adapt to such rapid changes. The present report summarizes the conclusions reached by this task-force. After a brief survey of the current optimal use and potential developments of neuroimaging in academic neurology, a set of recommendations and guidelines are proposed, which can be summarized as follows:
INTRODUCTION
Over the last 20 years, neuroimaging (as de®ned by techniques that image the living nervous system) has become both an integral part of clinical neurology and a major tool in neuroscience. Though neurological history and physical examination still are and will remain the cornerstone of neurological diagnosis, neuroimaging is ever increasingly used by both hospital-and practice-based neurologists in all steps of clinical management, from diagnosis to therapy. Thus, almost all neurological disorders nowadays require at least one, and often several, neuroimaging procedures for their diagnosis; considering the enormous prevalence of disorders such as stroke or dementia in our aging populations, the cost of neuroimaging procedures in health expenditure has become substantial and the market for the industry is huge. An ever-enlarging and sophisticated armamentarium makes use of a wide array of physical principles, from X-ray to electromagnetic source, and from ultrasound to radionuclides (Lentle and Aldrich, 1997; Kuikka et al., 1996) . The boundary between traditional medical disciplines is becoming less well de®ned as technology progresses and academic neurologists get increasingly involved in neuroimaging. Yet, neuroimaging is not always perceived positively by neurologists, who often place their clinical skills above the instruments and are reluctant to learn to use imaging techniques. Presently, neuroimaging is only poorly represented in the curriculum of neurology in European medical schools, and is not considered a sub-speciality of academic neurology in Europe. This is in marked contrast with the USA, where neuroimaging is one of the sub-specialities of the American Academy of Neurology, with of®cial recognition through both the American Society of Neuroimaging and well-de®ned credentials in neuroimaging (Gomez et al., 1995) . Since the place of neuroimaging in academic neurology will obviously continue to grow, a Task-force on neuroimaging was created by the EFNS in June 1996 to assess how academic neurology in Europe should adapt to such rapid changes. In the present report, after a rapid overview of the presently existing neuroimaging techniques as they apply to the brain, the current optimal use and potential developments of the main neuroimaging techniques in academic neurology will be brie¯y surveyed taking as examples a limited set of selected brain disorders, and as a conclusion several recommendations and guidelines for a better integration of neuroimaging in academic neurology in Europe will be proposed.
THE MAIN TECHNIQUES
The main neuroimaging techniques presently used to investigate the brain are tabulated in Table 1 . They comprise X-ray, ultrasound, magnetic resonance (MR), positron emission tomography (PET) and single-photon emission computed tomography (SPECT), brain electro-magnetic activity [BEMA, which includes electroencephalography (EEG) and magneto-encephalography (MEG)], trans-cranial magnetic stimulation (TCS), and infrared spectroscopy (IRS, also called non-invasive optical imaging). In Table 1 , the parameters that can be studied with neuroimaging have been arranged according to a gradient from structure to function, as it is recognised that there is no well-de®ned boundary between structure and function and that the results from structural and functional imaging are often discrepant and therefore complementary in order to get a full understanding of brain disorders. The meaning of the abbreviations used in this and other tables can be found in the Glossary. As stated above, and for the sake of concision, we will restrain this overview to brain disorders. Thus, the techniques to image the skull, the spine and spinal cord, the nerve roots and trunks, and the muscles will not be reviewed here, even though it is recognized that considerable progress as well as major potential developments regarding neuroimaging do exist in these areas.
As can be seen in Table 1 , several parameters such as perfusion, angiography or blood±brain barrier (BBB) leakage, can be assessed by several distinct techniques, whereas others, such as metabolic¯uxes, biochemical content and cytotoxic edema, are presently routinely accessible by one neuroimaging technique only. Conversely, the vertical axis illustrates that several techniques, such as MR or PET, provide access to a number of distinct parameters, while others like ultrasound and BEMA are somewhat less versatile.
Additional important characteristics of the different techniques not given in Table 1 include, for instance, spatial resolution, temporal resolution and capabilities for quantitation. These characteristics being rather evident and well known, they will not be described further here, the reader being referred to specialized reviews (Kuikka et al., 1996; Lentle and Aldrich, 1997) . Likewise, it is evident that ultrasound and MR techniques do not entail exposure to ionizing radiations. Furthermore, almost day-to-day updating of Table 1 would be necessary due to rapid technological and methodological developments. For instance, assessment of carotid artery bifurcation stenosis now appears possible with spiral computerized tomography (CT), and the measurement of metabolic¯uxes in the brain with magnetic resonance spectroscopy (MRS) and the stable isotopes 13 C and 17 O may soon become standard practice. Likewise, the rapid development of SPECT devices able to acquire images from positron-emitting radionuclides may one day make it possible to perform semi-quantitative investigations of the brain with 18 Flabeled radiopharmaceuticals, up till now restricted to fully-equipped PET centers. most academic neurologists as clinically important applications of neuroimaging procedures in an optimal setting, and for which a consensus was reached among the members of this Task-force. The interested reader will ®nd further detail in recent reviews, a selection of which can be found in the reference list. Needless to say, wide variability in the access to these techniques exist from department to department and from country to country, which make the real world a little less ideal. The brief survey below serves also to clearly illustrate the complementarity of structural and functional neuroimaging, as well as the loose boundaries between the two, in the investigation of brain disorders.
NEUROIMAGING TECHNIQUES IN ACADEMIC NEUROLOGY: CURRENT OPTIMAL USE IN SELECTED BRAIN DISORDERS
Further detail about the contents of Table 2 will be given below, but only for those applications that depart from everybody's daily practice of clinical neurology, that is, established knowledge (e.g. the use of CT in the diagnosis of meningiomas) will not be further reviewed.
Acute stroke A bunch of recent reports provide good evidence that PET imaging of cerebral blood¯ow (CBF) and cerebral metabolic rate of oxygen (CMRO 2 ) as well as SPECT perfusion imaging with 99m Tc-labeled HMPAO have clinical usefulness for the differential diagnosis of stroke, topographical assessment of ischemia, and prognostication and classi®cation of stroke syndromes (Baron, 1996a) . Though less ®rmly established as yet, diffusion-weighed (DW)-and perfusion-weighed (PW)-MRI appear to provide important and complementary information and should play an essential role in the assessment of acute stroke in the future (Warach et al., 1997) .
Carotid artery disease
Ultrasound assessment remains a key investigation of carotid artery disease provided it comprises all three of the following components: (i) continuous Doppler to assess cervical artery and ophthalmic artery hemodynamics; (ii) B-mode echotomography (preferably colorcoded) of the cervical arteries to assess degree of stenosis and plaque irregularities; and (iii) transcranial Doppler, not only to assess intracranial artery disease, collateral supply and vasoreactivity, but also to detect foramen ovale patency (with ultrasound contrast agent), and spontaneous microemboli (Touboul and Rougemont, 1993; Ackerman, 1995) . Direct anatomical visualization of the arterial tree is best performed by conventional angiography though MR angiography and spiral-CT angiography are promising non-invasive techniques. PET imaging of CBF, cerebral blood volume (CBV) and CMRO 2 , or SPECT imaging of perfusion combined with either vasodilatory challenge or CBV imaging, allows to assess the brain hemodynamic consequences of carotid-artery obstruction, of use for diagnosis of mechanism of stroke or transient ischemic attack (TIA), as well as for indications, planning and monitoring of carotid surgery (Frackowiak, 1986; Baron, 1996b; Heiss, 1995) . Recently, PW-MRI has emerged as another tool to provide information on cerebral hemodynamics (Bertheze Áne et al., 1997). Finally, BEMA techniques are useful adjuncts to monitor brain tolerance to reductions in perfusion pressure during carotid endarterectomy.
Dementia
Recent CT and MRI studies have documented the utility of the measurement of hippocampal atrophy for the diagnosis of Alzheimer's disease (AD) (Smith and Jobst, 1996) . It is also well established that PET and SPECT imaging of perfusion or cerebral metabolic rate of glucose (CMRglc) has diagnostic utility both for the detection of the disease even before structural imaging becomes positive, and for the etiologic classi®cation of dementias (Mazziotta et al., 1992; Herholz, 1995; Waldemar, 1995; Nordberg, 1996; Ryding, 1996) .
Parkinson's disease (PD) and movement disorders PET and SPECT imaging of dopamine (DA) presynaptic integrity (either with the false-neurotransmitter 18 Fuoro-L-DOPA or with cocaine-derived selective inhibitors of the DA re-uptake sites) allows us to map the degree and distribution of nigro-striatal DA ®ber loss, which is useful in differentiating among the parkinsonian syndromes (Weeks and Brooks, 1994) . Imaging of the post-synaptic striatal DA receptors (D 1 or D 2 subtypes) allows to detect striatal neuronal loss and is also useful to differentiate among the parkinsonian syndromes as well as among the choreic-dystonic syndromes (Weeks and Brooks, 1994) .
Epilepsy
Recent reports indicate that MRI using particular sequences (T 1 inversion recovery and T 2 FLAIR) together with MRI-based volumetric measurements of the hippocampal formation are particularly useful in detecting unilateral hippocampal sclerosis in patients with temporal lobe epilepsy (Duncan, 1997) . Both BEMA techniques [with three-dimensional (3D) source localization] and MRS have clinical utility in localizing the epileptogenic focus (Stefan et al., 1990; Garcia et al., 1995; Castillo et al., 1996) . The pre-operative work-up of medically-resistant focal epilepsy is also a well-established application of both PET (with interictal CMRGlc and benzodiazepine receptor ligands) and SPECT (which allows ictal perfusion imaging) (Sadzot, 1996; Andersen et al., 1996) .
Multiple Sclerosis (MS)
Apart from the well-established role of MRI in the diagnosis and follow-up of MS patients, gadolinium contrast magnetic resonance spectroscopy (Gd-MRI) is emerging as a potential tool to monitor disease activity in MS, especially to assess the effects of therapy in clinical trials (Evans et al., 1997) .
Brain tumors PET imaging of 18 F-FDG and/or 11 C-methionine uptake is now considered an established tool for diagnosis of histological grade and classi®cation of glial tumors (low-grade astrocytoma, oligodendroglioma, glioblastoma), as well as for diagnosis of relapse and differentiation of relapse from radiotherapy-induced necrosis (Heiss and Herholz, 1994; Derlon et al., 1997) . SPECT imaging with 201 Thallium or 99m Tc-MIBI also seems to have clinical utility for these indications .
Encephalopathies
The role of BEMA techniques in the differential diagnosis and classi®cation of the encephalopathies (metabolic, viral, toxic) is well established. Early temporal lobe dysfunction can be detected in the acute phase of herpetic encephalopathy by means of several functional neuroimaging techniques. In the leucoencephalopathies of childhood, which include metabolic diseases (e.g. adrenoleukodystrophy) and HIV infection, proton MR spectroscopy has proved of signi®cant help both for differentiating these disorders from one another, and for prognostication (ConfortGouny et al., 1995; Salvan et al., 1997; Wang et al., 1996) .
THE USE OF NEUROIMAGING IN NEUROLOGICAL RESEARCH
Neuroimaging has become one of the most rapidly expanding and scienti®cally productive areas in neurological research. This success rests on three main points: (i) an ever expanding and sophisticated array of neuroimaging techniques, with for instance major new applications of MR, developments in ultrasound techniques, spiral CT, increasing numbers of radioligands for SPECT, or an exquisite spatial resolution of new generation PET machines; (ii) major software developments for the analysis and display of the various imaging modalities, with e.g. fully automatic 3D superimposition of structural (e.g. MRI), functional (e.g. PET activation data, BEMA and TCS), and biochemical (MR spectroscopy) imaging modalities being now possible; and (iii) widespread awareness that neuroimaging is able to describe the structural and functional mechanisms not only of diseases of the central nervous system (CNS), but also of fundamental processes horizontal to the disease axis, e.g. the motor, visual, language and memory processes. It would obviously not be the place here to review all the research applications of neuroimaging, but a few particularly illustrative recent developments that open up novel potential applications for future clinical practice will be described in the following section. the main disease categories dealt with in the preceding sections to illustrate major potential clinical applications that are likely to emerge within the next few years. Speci®c comments regarding each of these examples will now be given.
THE FUTURE OF NEUROIMAGING IN ACADEMIC NEUROLOGY

Acute stroke
Early signs of infarction on unenhanced CT (and presumably also on sensitive T 2 -weighted MRI sequences such as FLAIR) are now known to be detectable in a sizeable fraction of the patients within 6 h from stroke onset (Von Von Kummer et al., 1997) . Likewise, perfusion imaging (obtained with PET or SPECT, and possibly also, PMR and Xe-CT), especially if combined with information regarding the physiologic status of cells (with PET, DWI, or MRS), allows to map the presence, extent and severity of ischemia at time of assessment (Bakker and Pauwels, 1997). These techniques thus provide a powerful tool for individually tailoring therapy and for triage of patients into therapeutic trials of selected agents. For instance, their use would permit exclusion from thrombolytic therapy of those patients either with spontaneous reperfusion or with already extensive irreversible damage (i.e. at risk of hemorrhagic transformation), while, selection of best potential responders for neuroprotection agents would use a different set of neuroimaging criteria (Baron et al., 1995) . Neuroimaging should also help in monitoring the effects of therapy, e.g. whether reperfusion has occurred after thrombolysis. The development of MR methods to image brain perfusion, such as with spin-tagging, should place multimodality MRI in an ideal position to cover all these applications in the near future. Another potential application of neuroimaging techniques, especially of PET and functional magnetic resonance imaging (fMRI), in stroke patients relates to rehabilitation, as with the possibility to map in a single patient the neuronal reorganization that is taking (or has already taken) place in his brain in response/adaptation to focal damage, it may become possible to tailor the kind of rehabilitation paradigm most likely to best bene®t this individual patient (Frackowiak, 1996; Pantano et al., 1995 Pantano et al., , 1996 Karbe et al., 1997) . In this ®eld, new avenues have recently been opened with the use of trans-cranial magnetic stimulation (TCS) (Barker et al., 1985; Pascual-Leone et al., 1994) ; for instance, relevant prognostic information may be derived from TCS in the early stage of stroke (Papisarda et al., 1996; Traversa et al., 1997 ).
Alzheimer's disease As already indicated above, assessment of hippocampal atrophy with CT or MRI appears to provide not only a sensitive means of early diagnosis of AD, but also a marker of disease progression (Smith and Jobst, 1996) . As such, it may in turn become a sensitive surrogate marker of therapeutic ef®cacy in trials aiming at slowing down or arresting the pathologic process. The same should apply as well to CBF and CMRGlc mapping with PET and/or SPECT. Finally, some reports have proposed a potential role for MR spectroscopy imaging as well as new BEMA techniques (highfrequency coherence and topography, cognitive potentials) in the differential diagnosis of the dementias (Moats et al., 1995; Kuikka et al., 1996) .
PD and Huntington's disease (HD)
A number of reports have provided convincing evidence that PET mapping of presynaptic DA terminals integrity with 18 F-DOPA is a reliable marker of fetal mesencephalic striatal graft function in PD (Kordower et al., 1995) . This presumably should also apply to other DA presynaptic markers with either PET or SPECT. Furthermore, this approach should also be of great utility in the individual pre-surgical planning of graft implantation, by localizing in stereotaxic space the parts of the striatum which appear the most denervated. Finally, the same strategy might also apply to neural grafting in HD, this time by means of postsynaptic markers of striatal cell loss such as D 1 or D 2 receptor radioligands (Torres et al., 1995) . Another application of PET/SPECT relates to the pharmacotherapy of PD, as it appears possible to predict the response to L-DOPA in individual patients with the D 1 /D 2 receptor imaging techniques (Oertel et al., 1993) . Loss of frontal components of somatosensory evoked potentials is frequently observed in PD, and this can be transiently reversed by apomorphine administration (Rossini et al., 1989; Cantello et al., 1991) .
Epilepsy
The use of functional neuroimaging methods in the planning of neurosurgical interventions has attracted considerable interest in recent years (Leblanc and Meyer, 1990; Grafton et al., 1994) . This implies the mapping, by means of PET, fMRI or BEMA 3D techniques (the latter by means of source localization), of the cortical areas involved in the execution of a given task, such as motor, language and so on, in relation to the zone to be removed, the aim being to avoid damaging the eloquent areas during surgery and thus reduce risks of major post-operative de®cit (Ganslandt et al., 1997) . Likewise, these techniques are also able to map the epileptogenic focus in patients with intractable seizures.
Brain Tumors
The pre-surgical mapping of cortical functions just described for the surgery of epilepsy equally applies to the the surgery of brain tumors. In addition, and apart from the established role of PET and SPECT, promising results are now appearing from MRS studies in the differenciation between tumor recurrence and radionecrosis (Moats et al., 1995; Tedeschi et al., 1997) .
Encephalopathies
In the near future, MRS should allow a biochemical signature in terms of neuronal vs glial dysfunction of the infectious, toxic, and metabolic encephalopathies, notably the inborn errors of metabolism, and perhaps also of peri-focal encephalopathies surrounding an area of brain damage (Vion-Dury et al., 1994) . More generally, the conjunction of MRS, BEMA techniques and PET/SPECT imaging should permit the detection, characterization and categorization of functional (i.e. without detectable structural changes) encephalopathies, either diffuse or focal.
RECOMMENDATIONS
With neuroimaging taking an ever-growing importance both in the management of the neurological patient from diagnosis to therapy and in the neurological sciences, and functional neuroimaging requiring everincreasing knowledge about neurophysiology, the question one needs to ask today is: how could academic neurology better incorporate neuroimaging within its activities? To address this question is to raise the following two intermingled issues: (1) the place of neuroimaging in the future organization of neurology departments; and (2) the role of the neurologist in the implementation and interpretation of neuroimaging procedures in relation to the other traditional medical disciplines. This in turn raises two additional issues: (i) the training of future neurologists in neuroimaging; and (ii) the place of neuroimaging in post-graduate education, professional meetings and neurological research. These are complex and at times thorny issues, however, for which the balanced recommendations and guidelines that will be given below reached a dif®cult consensus among the members of this task-force. The viewpoint that will be given here is of®cially endorsed by the EFNS.
(1) The place of neuroimaging in the future organization of neurology departments: the main question to be considered is``Should neuroimaging tools be installed within neurology departments, and, if so, which tools ?'' As a matter of fact, such an``ideal'' situation already exists in many places for ultrasound (with for instance neurosonology being a necessary part of any``stroke unit'') and BEMA techniques, but this only exceptionally applies to MR, CT, SPECT or PET. Clearly, the issue regarding the latter techniques is one of regulations, as in most European countries speci®c specialty degrees (e.g. radiology, nuclear medicine) are presently required to purchase and run such pieces of equipment. In Austria, Denmark and Germany, however, a special permission to use a speci®c neuroimaging technique (e.g. PET, SPECT, MR) for an application exclusively in neurology can be granted to someone under speci®c circumstances and according to his/her speci®c skills; this creates interdisciplinary disputes, however, and is under threat of disappearing with European harmonization. Thus, more realistic models need to be considered, the most obvious one being large``neuro'' departments merging neurology, neurosurgery, clinical neurophysiology, neuroradiology, neuronuclear medicine and neurorehabilitation (and possibly in some instance psychiatry as well). Such settings indeed clearly offer the multi-disciplinarity within which neuroimaging would easily ®t and expand at the patient's bene®t. In such settings, the machines and ancillary equipment would not``belong'' to a single academic discipline, but would be purchased and run on a service basis, i.e. shared between the different disciplines, even though certi®ed radiologists/nuclear physicians may retain primary responsibility for the maintenance, technical staff and scheduling of those devices that involve ionizing radiations. This would imply huge savings in terms of both money and space. In addition, such an organization also allows more effective training in neuroimaging to both medical students and neurology residents for incorporation within residency programs, as well as improved opportunities for research. Though still rare, large``neuro'' departments already exist in several European University Hospitals (e.g. Rome, Heidelberg, Groningen, Copenhagen), and have proved both ef®cient and successful, as well as viable. An extreme case is that of cardiology, with coronarography and angioplasty being incorporated within and belonging to big cardiology departments in several European countries. Finally, in the case of extremely costly equipment such as MR or PET, a service organization between``neuro'' and`n on-neuro'' users is a further interesting approach.
(2) The role of the neurologist in the implementation and interpretation of neuroimaging procedures in relation to the other traditional medical disciplines: this is a most complex issue, as regulations need to be taken into account but differ according to each type of imaging technology and each European country (yet do not always appear to be followed strictly !). Thus, while ultrasound is part of radiology in the UK, in most European countries any certi®ed physician can practice it without the need to have of®cial certi®cation. In the case of acute stroke units, neurosonology is often carried out by the neurologist in charge, and this should be the rule whenever possible. Neurosonology is almost entirely in the hands of neurologists in Norway and Germany. BEMA techniques are a subspecialty of neurology (with an EEG board certi®cation) in most European countries, but in France any physician can perform them provided certi®cation by an EEG Board has been obtained. Academic clinical neurophysiology exists as a separate specialty in eight countries of the EU, while in the remaining it is usually incorporated within neurology departments (in France, it is usually part of general physiology). Being quali®ed in clinical medicine, most neurophysiologists care for out-patients (and, in Germany, for in-patients too) with disorders such as epilepsy, sleep disorders or chronic pain. Regarding neuroradiology (i.e., X-rays and MR), it is part of Radiology in all European countries, with only Italy, Germany and Portugal having it as a subspecialty of radiology (entailing a 1-year residency in clinical neurology). In all European countries, one needs to be a radiologist to be allowed to run X-ray or MR equipments (except again in Austria, Denmark and Germany, under special circumstances; see also the case of the USA, below). The almost general situation in Europe is that when it comes to medical practice, one has to choose among the specialties even if one has obtained board certi®cation for two specialties; this especially applies to radiology, the aim being to prevent`s elf-referral'' practices (Levin, 1994) . The situation is, however, complicated as with the advent of``interventional neuroradiology'', neuroradiologists have also become therapists. Regarding nuclear medicine, in no European country (except again Austria, Germany and Denmark) can a neurologist use radio-isotopes unless he/she also possesses the speci®c degree, which in some countries is incorporated within radiology and in others is a separate specialty.
This situation is to be criticized as it does not take into account the tremendous changes in neurological practice that have taken place as a result of progresses in neuroimaging. Regulations must be made morē exible so that neuroimaging may, under well-de®ned circumstances and according to clear rules, be practiced by neurologists either as an addition to their normal neurological practice, or in place of part of it. Such a policy would also make sense on a health-expenditure point of view, as it seems obvious that fewer useless neuroimaging procedures would be performed if the referring neurologist knew what these tests might be able to show in a given clinical situation. Three recommendations are proposed as a generalized system to better incorporate neuroimaging as part of academic neurology: (i) that Neuroradiology, as an independent medical specialty dealing mainly with structural neuroimaging, includes in its training at least 1 (as is already the case in Germany), and preferably 2, years of clinical neurology; (ii) that a new medical (sub) specialty in``functional neuroimaging'' (i.e. not including diagnostic structural neuroimaging) be created, which would entail either a full neurology training with an additional training in the relevant neuroimaging techniques and the basic neurosciences, or, perhaps more realistically, a less extensive clinical training allowing only a partial practice of neurology (see below regarding the situation in the US); and (iii) that a system of``credentials'' be created, according to which any certi®ed neurologist would be entitled to obtain additional certi®cations in speci®c neuroimaging techniques, including interventional neuroradiology, following proper (and accreditated) training, as is the case for cardiologists, who presently practice most coronary angiography and angioplasty procedures in Europe and the USA (Sunshine et al., 1993) .
To better grasp the issues involved, it is useful to consider the situation in the USA where the latter system is already operational, though this does not go without problems. The whole issue of neuroimaging has lately attracted considerable attention there, with one result being the creation, under the auspices of the American Academy of Neurology (AAN), of the American Society for Neuroimaging (ASN). The latter society has endorsed in March 1996 a set of``Guidelines for Credentialing in Neuroimaging'' (Gomez et al., 1995) . This document states the policy of the AAN as approved by its Board in 1975, as follows:``Neuroimaging is an integral part of the practice of neurology, that requires broad knowledge of neuroanatomy, neuropathology, pathophysiology, and clinical neurologic disorders. Proper interpretation of neuroimaging requires knowledge of the effects of disease on the neuroimaging examination, its indications, performance and interpretation''. In addition, the American Medical Association (AMA) has clearly stated its position with regard to jurisdictional disputes among medical specialists:``The AMA believes that (1) individual character, training, competence, experience and judgement should be the criteria for granting privileges in hospitals; and (2) physicians representing several specialties can and should be permitted to perform the same procedures if they meet these criteria''. These recommendations were further rati®ed by the AMA in 1994, with statements that any kind of exclusion of a given medical discipline from performing an act is at the expense of the quality of patient care. This document then proposes a set of training credentials the importance of which depend on whether performance and interpretation, or independent operation of neuroimaging facilities, is concerned. As a result, any neurologist ful®lling the relevant credentials (certi®ed by the ASN following rigourous written examinations) may practice neuroradiology in the USA. However, this does not go without problems, as shown by a recent editorial in the journal Neurology, entitled`T he neurologist as neuroimager'' (Brillman et al., 1997) , which recounts that some health insurers in the US now have implemented restrictive reimbursement policies with respect to interpretation of MRI studies by non-radiologists, the objective being to con®ne health costs by constraining self-referral habits (Levin, 1994) . This paper indicates that a new pathway recently created will eventually allow neurologists to have 2 years of general radiology training, which, on top of 1 year of general medicine, 2 years of neurology and 2 years of neuroradiology, would allow them to take both boards of neurology and neuroradiology (i.e. model 1 above). Thus, the existing possibility for neurologists in the US to obtain quali®cations for performance and interpretation of CT, MRI/magnetic resonance angiography (MRA) and neurosonology may become restricted due to changes in reimbursement policies by insurers, threatening the entire system.
The readers of the present Report are encouraged to forward to the Chairman of this task-force, via letters to the Editor of the EJN, all relevant comments and suggestions they may have on this topic, especially regarding the regulations in their own country.
(3) the training of future neurologists in neuroimaging: pending the changes just proposed, training in neuroimaging must be incorporated as soon as possible within neurology training. Only by doing so will neuroimaging become more generally accepted as part of the normal practice of neurology. This is already ongoing in the USA, and at a workshop sponsored by the AAN in 1993 that included directors of 33 neurology training programs, three levels of competence in neuroimaging were de®ned: (I) Diagnostic expertise for most neurologic disorders. This level should be achieved by the end of residency training in neurology. (II) Expertise in all clinical and basic aspects of a given modality. It is believed that this level should be required to operate an independent imaging laboratory. Fellowship training is recommended as a PGY 5-6 addition to an approved neurology residency. (III) Research expertise, advisable for neurology residents and imperative for neuroimaging fellows.
If this is to become a reality in Europe, an important part of the training in neuroimaging will need to be provided by those academic neurologists in charge of the curriculum of neurology, who therefore have to learn about the basics and practice of neuroimaging. To make this possible, chairs of neuroimaging need to be created within academic neurology departments, as already exists in a few Universities in Europe.
(4) The place of neuroimaging in post-graduate education, professional meetings, and neurological research: to raise an interest in neuroimaging from the part of academic neurologists, a larger place should be given to neuroimaging in national and European neurology meetings, including EFNS congresses, in both their teaching and their scienti®c sessions. Special awards could also be implemented. In the US, as stated in the same editorial of Neurology,``specialized continuing education in neuroimaging is available to all neurologists, with frequent courses sponsored by both the AAN and the ASN as part of their annual meetings. In addition, special fellowships in neuroimaging are available or are in the process of being established, offering 1 or 2 years of specialized training in all scienti®c and clinical aspects of neuroimaging. The combination of training during neurology residency, specialized courses, postgraduate training, and available certi®cation by the ASN provide for neurologists a peer-reviewed system to guarantee high quality of care in the practice of neuroimaging''; but``further effort to establish neuroimaging fellowships as part of postgraduate training in well-established neurology programs should be a priority''. These guidelines should inspire, and eventually equally apply to, academic Neurology in the EC. 
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